Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Operating Expenses | 15,082 | 6,052 | 3,033 | 0 |
| Operating Income | -15,082 | -6,052 | -3,033 | N/A |
| Interest Expense | 209 | 42 | 0 | 0 |
| Other Income | -1,418 | -8 | -93 | 0 |
| Pre-tax Income | -16,709 | -6,102 | -3,126 | 0 |
| Net Income Continuous | -16,709 | -6,102 | -3,126 | N/A |
| Net Income | $-16,709 | $-6,102 | $-3,126 | $N/A |
| EPS Basic Total Ops | -53.40 | -21.80 | -11.80 | N/A |
| EPS Basic Continuous Ops | -49.52 | -19.08 | -10.92 | N/A |
| EPS Diluted Total Ops | -53.40 | -21.80 | -11.80 | N/A |
| EPS Diluted Continuous Ops | -49.52 | -19.08 | -10.92 | N/A |
| EBITDA(a) | $-14,892 | $-5,964 | $-3,008 | $N/A |